Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease

Blood Cells, Molecules, and Diseases

Volumn 52, Issue 4, 2014, Pages 195-202

  Reid, Marion E ^a   Hipsky, Christine Halter ^a,c   Hue Roye, Kim ^a   Hoppe, Carolyn ^b  

^a NEW YORK BLOOD CENTER   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c Roche Diagnostics Corporation   (United States)

Author keywords

Blood groups; Compatibility testing in sickle cell disease; DNA testing to predict blood groups; RH blood group system; RH genotype matching

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; RHESUS ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; DNA PROBE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RH GENE; SEQUENCE ANALYSIS; SICKLE CELL ANEMIA;

BLOOD GROUPS; COMPATIBILITY TESTING IN SICKLE CELL DISEASE; DNA TESTING TO PREDICT BLOOD GROUPS; RH BLOOD GROUP SYSTEM; RH GENOTYPE MATCHING;

ALLELES; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; GENE FREQUENCY; GENETIC VARIATION; GENOMICS; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; RH-HR BLOOD-GROUP SYSTEM; TREATMENT OUTCOME;

EID: 84895538576     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2013.11.003     Document Type: Article

References (55)

1. Aygun B., Padmanabhan S., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion (Paris) 2002, 42(1):37-43.
2. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion (Paris) 1997, 37(4):357-361.
3. Giblett E.R. Blood group alloantibodies: an assessment of some laboratory practices. Transfusion (Paris) 1977, 17(4):299-308.
4. Heddle N.M., Soutar R.L., O'Hoski P.L., et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br. J. Haematol. 1995, 91(4):1000-1005.
5. Hoeltge G.A., Domen R.E., Rybicki L.A., Schaffer P.A. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch. Pathol. Lab. Med. 1995, 119(1):42-45.
6. Redman M., Regan F., Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang. 1996, 71(4):216-220.
7. Rosse W.F., Gallagher D., Kinney T.R., et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990, 76(7):1431-1437.
8. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med. 1998, 339(1):5-11.
9. Miller S.T., Wright E., Abboud M., et al. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J. Pediatr. 2001, 139(6):785-789.
10. Adams R.J., Brambilla D. Optimizing primary stroke prevention in sickle cell anemia trial I. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N. Engl. J. Med. 2005, 353(26):2769-2778.
11. Adams R.J., Brambilla D.J., Granger S., et al. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood 2004, 103(10):3689-3694.
12. Abboud M.R., Yim E., Musallam K.M., Adams R.J., Investigators S.I.S. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood 2011, 118(4):894-898.
13. Vichinsky E.P., Neumayr L.D., Gold J.I., et al. Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 2010, 303(18):1823-1831.
14. Howard J., Malfroy M., Llewelyn C., et al. The Transfusion Alternatives Preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet 2013, 381(9870):930-938.
15. Josephson C.D., Su L.L., Hillyer K.L., Hillyer C.D. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines. Transfus. Med. Rev. 2007, 21(2):118-133.
16. Lionnet F., Arlet J.B., Bartolucci P., et al. Guidelines for management of adult sickle cell disease. Rev. Med. Interne 2009, 30(Suppl. 3):S162-S223.
17. Wanko S.O., Telen M.J. Transfusion management in sickle cell disease. Hematol. Oncol. Clin. North Am. 2005, 19(5):803-826. (v-vi).
18. Drasar E., Igbineweka N., Vasavda N., et al. Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years. Br. J. Haematol. 2011, 152(6):766-770.
19. Talano J.A., Hillery C.A., Gottschall J.L., Baylerian D.M., Scott J.P. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics 2003, 111(6 Pt 1):e661-e665.
20. Vichinsky E.P., Earles A., Johnson R.A., Hoag M.S., Williams A., Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood [see comments]. N. Engl. J. Med. 1990, 322(23):1617-1621.
21. King K.E., Shirey R.S. Transfusion management of patients with sickle cell disease: the continuing dilemma. Transfusion (Paris) 2010, 50(1):2-4.
22. Natukunda B., Schonewille H., Ndugwa C., Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion (Paris) 2010, 50(1):20-25.
23. Olujohungbe A., Hambleton I., Stephens L., Serjeant B., Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br. J. Haematol. 2001, 113(3):661-665.
24. Sosler S.D., Jilly B.J., Saporito C., Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am. J. Hematol. 1993, 43(2):103-106.
25. Tahhan H.R., Holbrook C.T., Braddy L.R., Brewer L.D., Christie J.D. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion (Paris) 1994, 34(7):562-569.
26. Vichinsky E.P., Luban N.L., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion (Paris) 2001, 41(9):1086-1092.
27. Chou S.T., Jackson T., Vege S., Smith-Whitley K., Friedman D.F., Westhoff C.M. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013, 122(6):1062-1071.
28. Miller S.T., Kim H.Y., Weiner D.L., et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion (Paris) 2013, 53(4):704-709.
29. O'Suoji C., Liem R.I., Mack A.K., Kingsberry P., Ramsey G., Thompson A.A. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr. Blood Cancer 2013, 60(9):1487-1491.
30. Reid M.E., Lomas-Francis C., Olsson M.L. The Blood Group Antigen FactsBook 2012, Elsevier. 3rd ed.
31. AABB Technical Manual 2008, American Association of Blood Banks, Bethesda. 16th edition.
32. Patnaik S.K., Helmberg W., Blumenfeld O.O. BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res. 2012, 40(Database issue):D1023-D1029.
33. Wagner F.F., Flegel W.A. RHD gene deletion occurred in the Rhesus box. Blood 2000, 95(12):3662-3668.
34. Singleton B.K., Green C.A., Avent N.D., et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000, 95(1):12-18.
35. Chiu R.W., Murphy M.F., Fidler C., Zee B.C., Wainscoat J.S., Lo Y.M. Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clin. Chem. 2001, 47(4):667-672.
36. Vege S., Westhoff C.M. Identification of altered RHD and RHCE alleles: a comparison of manual and automated molecular methods. BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis 2011, 122-131. Springer Science+Business Media, New York. P.M. Ness, J.M. Moulds, S.R. Sloan (Eds.).
37. Reid M.E., Halter Hipsky C., Looking Beyond H.E.A. Matching SCD patients for RH variants. BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis 2011, 101-120. Springer Science+Business Media, New York. P.M. Ness, J.M. Moulds, S.R. Sloan (Eds.).
38. Hashmi G., Zhang H., Seul M. The BeadChip system: a flexible array format for complex nucleic acid and protein analysis. BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis 2011, 17-32. Springer Science+Business Media, New York. P.M. Ness, J.M. Moulds, S.R. Sloan (Eds.).
39. Podual K., Zhang H., Mezokh N., Yang J., Wilson R. Bayesian classification algorithms for automated allele assignment. BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis 2011, 133-148. Springer Science+Business Media, New York. P.M. Ness, J.M. Moulds, S.R. Sloan (Eds.).
40. Westhoff C.M., Vege S., Halter-Hipsky C., et al. DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion (Paris) 2010, 50(6):1303-1311.
41. Avent N.D., Martinez A., Flegel W.A., et al. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion (Paris) 2007, 47(1 Suppl.):40S-46S.
42. Beiboer S.H., Wieringa-Jelsma T., Maaskant-Van Wijk P.A., et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion (Paris) 2005, 45(5):667-679.
43. Bugert P., McBride S., Smith G., et al. Microarray-based genotyping for blood groups: comparison of gene array and 5'-nuclease assay techniques with human platelet antigen as a model. Transfusion (Paris) 2005, 45(5):654-659.
44. Denomme G.A., Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion (Paris) 2005, 45(5):660-666.
45. Hashmi G., Shariff T., Seul M., et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion (Paris) 2005, 45(5):680-688.
46. Hashmi G., Shariff T., Zhang Y., et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion (Paris) 2007, 47(4):736-747.
47. Westhoff C.M. Molecular testing for transfusion medicine. Curr. Opin. Hematol. 2006, 13(6):471-475.
48. Denomme G.A., Johnson S.T., Pietz B.C. Mass-scale red cell genotyping of blood donors. Transfus. Apher. Sci. 2011, 44(1):93-99.
49. Noizat-Pirenne F., Lee K., Pennec P.Y., et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002, 100(12):4223-4231.
50. Lomas-Francis C., Yomtovian R., McGrath C., Walker P.S., Reid M.E. A confusion in antibody identification: anti-D production after anti-hrB. Immunohematology 2007, 23(4):158-160.
51. Westhoff C.M., Vege S., Halter Hipsky C., et al. RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa. Transfusion (Paris) 2013, 53(4):741-746.
52. Hemker M.B., Ligthart P.C., Berger L., van Rhenen D.J., van der Schoot C.E., Wijk P.A. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999, 94(12):4337-4342.
53. Danzer M., Niklas N., Stabentheiner S., et al. Rapid, scalable and highly automated HLA genotyping using next-generation sequencing: a transition from research to diagnostics. BMC Genomics 2013, 14:221.
54. English A.C., Richards S., Han Y., et al. Mind the gap: upgrading genomes with Pacific Biosciences RS long-read sequencing technology. PLoS One 2012, 7(11):e47768.
55. Gullapalli R.R., Desai K.V., Santana-Santos L., Kant J.A., Becich M.J. Next generation sequencing in clinical medicine: challenges and lessons for pathology and biomedical informatics. J. Pathol. Inform. 2012, 3:40.